Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (63) clinical trials

Study participation will last four weeks, and all eligible participants will receive the following at no cost: All study-related medications All study-related care and monitoring All study-related visits with our team of medical professionals    

Phase N/A

Financial compensation may be provided for time and travel expenses.  

Phase N/A

The POETYK PSO Study will look at how safe, effective and long-lasting an oral study drug is in individuals with moderate-to-severe plaque psoriasis.  

Phase

A research study is evaluating an investigational medication for moderate to severe plaque psoriasis.  

Phase N/A

This is a 32 week study evaluating the effectiveness of a potential new oral medication for genital plaque psoriasis.  

Phase

A new nationwide clinical trial studying new psoriasis treatments for children is now enrolling. If you child has plaque psoriasis, he/she may be eligible to participate in a clinical study to help evaluate a potential new oral medication.  

Phase

The purpose of this study is to investigate the experimental medication BMS-986165 compared to placebo and a currently available treatment in participants with moderate to severe plaque psoriasis.  

Phase

Right now, the DISCREET clinical research study is enrolling people who have genital psoriasis. Researchers are testing an investigational drug to learn whether it can relieve symptoms and potentially reduce and/or eliminate genital psoriasis.  

Phase

Pregnancy and Medically Assisted Conception in Rare Diseases

Rare diseases frequently affect women of childbearing age. Pregnancy in these women has become less rare, but remains associated with high levels of complications. One obstacle to their optimal management during pregnancy is that there are no prospective studies of pregnancy during rare diseases and several connective tissue diseases. As ...

Phase N/A

Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases

Introduction: The medical treatment of inflammatory rheumatic diseases has improved dramatically during the last decades primarily due to the introduction of biological disease modifying anti-rheumatic drugs (bDMARDs). However, bDMARD treatment failure occurs in 30-40% of patients due to lack of effectiveness or side effects. The tools to predict treatment outcomes ...

Phase N/A